Drug Type Small molecule drug |
Synonyms Oral CDK4 inhibitor |
Target |
Action inhibitors |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Australia | 09 Apr 2024 | |
Colorectal Cancer | Preclinical | Australia | 09 Apr 2024 | |
Glioblastoma | Preclinical | Australia | 09 Apr 2024 |